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ttp://dx.doi.org/10.1016/j.ajpath.2013.01.005Severe sepsis is a life-threatening disease that causes major morbidity and mortality. Catecholamines
and glucocorticoids often have been used for the treatment of sepsis. Several recent studies have
suggested a potential role of IL-17 during the development and progression of sepsis in small animal
models. In this study, the cross-talk of catecholamines and glucocorticoids with members of the IL-17
family was investigated during sepsis in C57BL/6 mice. The concentrations in plasma of IL-17A, IL-17F,
and the IL-17AF heterodimer all were increased greatly in mice after endotoxemia or cecal ligation and
puncture as compared with sham mice. Surprisingly, when compared with IL-17A (487 pg/mL), the
concentrations of IL-17F (2361 pg/mL) and the heterodimer, IL-17AF (5116 pg/mL), were much higher
12 hours after endotoxemia. After surgical removal of the adrenal glands, mice had much higher
mortality after endotoxemia or cecal ligation and puncture. The absence of endogenous adrenal gland
hormones (cortical and medullary) was associated with 3- to 10-fold higher concentrations of IL-17A,
IL-17F, IL-17AF, and IL-23. The addition of adrenaline, noradrenaline, hydrocortisone, or dexameth-
asone to lipopolysaccharide-activated peritoneal macrophages dose-dependently suppressed the
expression and release of IL-17s. The production of IL-17s required activation of c-Jun-N-terminal
kinase, which was antagonized by both catecholamines and glucocorticoids. These data provide novel
insights into the molecular mechanisms of immune modulation by catecholamines and glucocorticoids
during acute inﬂammation. (Am J Pathol 2013, 182: 1124e1130; http://dx.doi.org/10.1016/j.
ajpath.2013.01.005)Supported by NIH grants GM-29507 and GM-61656 (P.A.W.), the
Deutsche Forschungsgemeinschaft (Project 571701, BO 3482/1-1 to M.B.),
the Federal Ministry of Education and Research (BMBF 01EO1003 to
M.B.), and the Boehringer Ingelheim Fonds (R.R.).More than 600,000 cases of sepsis occur annually in the
United States, with mortality rates ranging from 20% to
30%.1,2 The pathophysiology of sepsis is poorly understood.
Sepsis often involves the spread of a localized infection
(bacterial, fungal), resulting in the acute systemic inﬂam-
matory response syndrome with mediator release, followed
by lymphocyte apoptosis and accompanying immuno-
suppression.3e6 We and others recently reported on the
involvement of IL-17 during sepsis.7e9 The ﬁrst described
IL-17 family member, IL-17A, is a dimeric, glycosylated
protein (35 kDa) that originally was described as a product
from activated T cells.10 Several other isoforms (IL-17s) also
are known, with IL-17F displaying the highest homology
(approximately 40%) to IL-17A.11,12 Notably, IL-17A and
IL-17F can form either disulﬁde-linked homodimers or het-
erodimers (IL-17AF). Recent data indicate a 10- to 30-fold
higher biological potency for IL-17A as compared withstigative Pathology.
.IL-17F, with IL-17AF displaying intermediate activity.13
Several studies have suggested that IL-17 family members are
not derived exclusively fromCD4þ T cells (Th17); they also are
expressed by a broad spectrum of immune and inﬂamma-
tory cells, including polymorphonuclear leukocytes, macro-
phages, monocytes, lymphocyte tissue-inducer cells, invariant
natural killer T cells, gdT cells, and Paneth cells.7,8,14e16 In
a recent study using IL-17A reporter mice, gdT cells were the
predominant source of this cytokine during Pseudomonas
pneumonia.17 In vivo neutralization of gdT cellederived
IL-17A improved survival in polymicrobial sepsis induced by
cecal ligation and puncture (CLP).8 Likewise, blockade of
Adrenal Hormones Suppress IL-17IL-17A was protective after lethal endotoxemia in mice.7 In
Bacteroides fragilis infection, neutralization of IL-17A pre-
vented the formation of abscesses.18 On the other hand, peri-
toneal clearance of Escherichia coli was impaired by
neutralization of IL-17A, indicating that certain levels of
IL-17A are protective during the early phases of infection.9
Collectively, accumulating evidence suggests a role of IL-17
family members during sepsis and related diseases. How-
ever, it also is clear that these cytokines have important func-
tions in mediating immune defenses against infections.
Currently, no Food and Drug Administrationeapproved
drugs are available to improve the outcome of sepsis. Besides
modern interventions of critical care medicine (low tidal
volume mechanical ventilation, ﬂuid resuscitation, and so
forth), low-dose glucocorticoids and catecholamines have been
used as supportive treatments for patients with sepsis.19 Here,
we report on the immune modulatory functions of glucocorti-
coids and catecholamines related to the appearance of IL-17
isoforms during two experimental models of sepsis in mice.
Materials and Methods
Research Animals
The studies were performed in accordance with the guidelines
of the US NIH and received approval from the University
Committee on Use and Care of Animals of the University of
Michigan. Male C57BL/6 mice (10-12 weeks old) were
purchased from The Jackson Laboratory (Bar Harbor, ME).
Surgical adrenalectomy was performed by Taconic Farms, Inc.
(Germantown, NY), with sham mice receiving anesthesia and
surgical incisions without removal of adrenal glands. After
adrenalectomy, mice were maintained on 0.9% NaCl as
drinking water. Mice were allowed at least 10 days after
adrenalectomy for recovery from the surgical procedure before
use in further experiments. All animals were housed under
speciﬁc pathogen-free conditions.
Endotoxemia
Mice received 10 mg/kg body weight intraperitoneal injec-
tion of lipopolysaccharide (7 mg/kg body weight for
survival studies) from E. coli (0111:B4; Sigma-Aldrich, St.
Louis, MO) and EDTA blood was obtained as described
previously.7 For survival studies, mice were monitored at
least every 12 hours for a duration of 10 days.
Cecal Ligation and Puncture
Ketamine-/xylazine-induced anesthesia followed by ligation
and bilateral puncture of the cecum using an 18-/23-gauge
needle plus ﬂuid resuscitation was performed as described
elsewhere.20 Control mice (sham-OP) received anesthesia
and a midline incision without manipulation of the cecum.
Blood collection or monitoring of survival was performed as
described in the paragraph above.The American Journal of Pathology - ajp.amjpathol.orgPeritoneal-Elicited Cells
Peritoneal-elicited cells (PECs) (>80% F4/80þCD11bþ)
were collected 4 days after injection of 2.4% thioglycollate
and cultured in RPMI 1640 media containing 100 U/mL
penicillin-streptomycin, 0.1% bovine serum albumin, and
25 mmol/L HEPES.7,14 Cell-free supernatant ﬂuids were
stored at 80C until further analysis.
ELISA
Detection of mouse IL-17A, IL-17F, IL-17AF, and IL-23
was accomplished by sandwich enzyme-linked immuno-
sorbent assay (ELISA) (R&D Systems, Minneapolis, MN)
according to the manufacturer’s instructions. We found that
there was no cross-reactivity between the ELISA from IL-17
family members, further validating the manufacturer’s
assurance (data not shown).
Real-Time PCR
Total RNA was isolated, reverse-transcribed, and ampliﬁed
as described earlier.14,21 The following primers were used:
mouse IL-17A (forward) 50-CTCCAGAAGGCCCTCAG-
ACTAC-30, mouse IL-17A (reverse) 50-AGCTTTCCCTC-
CGCATTGACACAG-30, mouse glyceraldehyde-3-phosphate
dehydrogenase (forward) 50-TACCCCCAATGTGTCCGTC-
GTG-30, mouse glyceraldehyde-3-phosphate dehydrogenase
(reverse) 50-CCTTCAGTGGGCCCTCAGATGC-30 (all from
Invitrogen, Carlsbad, CA), and mouse IL-17F (QT00144347;
Qiagen, Valencia, CA). Relative expression levels were
calculated using the 2DDCt method.
Bead-Based Assays
The cells were lysed (Bio-Plex Cell Lysis Kit; Bio-Rad,
Hercules, CA) and incubated with beads coated with anti-
bodies speciﬁc for c-Jun-N-terminal kinase (JNK) phos-
phorylated at Thr183/Tyr185 according to the manufacturer’s
instructions. Samples were analyzed on a Luminex xMAP/
Bio-Plex-200 System with Bio-Plex Manager Software 5.0
(Bio-Rad) as described previously.20 For data analysis, ﬂuo-
rescence intensities were normalized to signals from lysates
of untreated cells.
Reagents
The following reagents were used for the studies: lipopoly-
saccharide (LPS) from E. coli (0111:B4; Sigma-Aldrich),
adrenaline (Hospira, Inc., Lake Forest, IL), noradrenaline
(Hospira, Inc.), hydrocortisone (Sigma-Aldrich), dexa-
methasone (APP Pharmaceuticals, LLC, Schaumburg, IL),
SP600125 (InvivoGen, San Diego, CA), and AEG3482
(Tocris Bioscience, Park Ellisville, MO). Neutralizing
polyclonal goat anti-mouse IL-23p19 IgG and normal goat
IgG were from R&D Systems.1125
Figure 1 Expression and release of IL-17 family members during polymicrobial sepsis or endotoxemia. A: Relative expression levels of mRNA for IL-17A in
spleen homogenates from C57BL/6 mice (n  6, each group) 8 hours after CLP or sham surgery. B: Relative expression levels of mRNA for IL-17F in spleen
homogenates from the same experiment. C: Comparison of plasma concentrations of IL-17A, IL-17F, and IL-17AF at various time points after endotoxemia,
using 10 mg/kg body weight LPS, in C57BL/6 mice (n Z 4 to 5 for each time point, ELISA). *P < 0.05.
Bosmann et alStatistical Analysis
In vitro experiments were performed independently at least
three times and in vivo experiments were performed with the
number of mice indicated in Figure 1 and 2. All values are
expressed as the mean, and error bars represent the SEM.Figure 2 Increased plasma levels of IL-17 family members after adrenalectom
LPS, of C57BL/6 mice after ADRX (nZ 5) or mice after sham ADRX (sham-OP, nZ
10 mg/kg body weight LPS, in mice after sham-OP or ADRX (n  8 per group). C: P
Plasma concentrations of the IL-17AF heterodimer from the same experiment as
shown in B. F: Detection of IL-17A in plasma of C57BL/6 mice 12 hours after endot
IgG i.p. (nZ 5) or 10 mg control IgG i.p. (nZ 5). G: Survival rates of C57BL/6 m
days before CLP. H: Plasma concentrations of IL-17A at 8 hours after CLP in mice
the ADRX and CLP protocols served as additional controls (n  3 per group). I: Pl
Plasma concentrations of the IL-17AF heterodimer from the same experiment as
1126Data shown in the ﬁgures were analyzed by an unpaired,
two-tailed Student’s t-test, and survival curves were
analyzed by the log-rank (Mantel-Cox) test (GraphPad
Prism version 5.04; GraphPad Software Inc., La Jolla, CA).
Differences were considered signiﬁcant when the P value
was less than 0.05. The cytokine concentrations werey (ADRX). A: Survival curves after endotoxemia, using 7 mg/kg body weight
5). B: Plasma concentrations of IL-17A at 8 hours after endotoxemia, using
lasma concentrations of IL-17F from the same experiment as shown in B. D:
shown in B. E: Detection of IL-23 in plasma from the same experiment as
oxemia. Mice were pretreated with 10 mg neutralizing polyclonal antieIL-23
ice after CLP. Mice underwent either sham-OP (nZ 10) or ADRX (nZ 8) 14
after sham-OP or ADRX. Mice that underwent only sham procedures for both
asma concentrations of IL-17F from the same experiment as shown in H. J:
shown in H. *P < 0.05, **P < 0.01, and ***P < 0.001.
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Adrenal Hormones Suppress IL-17determined from log-transformed standard concentrations
on a standard curve and then subjected to statistical analysis.
Results
Hyperproduction of IL-17 Family Members during
Endotoxemia and Polymicrobial Sepsis after
Adrenalectomy
We recently reported on the production of IL-17A and IL-
17F isoforms in experimental sepsis models.7,8,14,20 After
CLP, the levels of mRNA for IL-17A and IL-17F were
increased in spleen homogenates 8 hours after CLP, when
compared with mice after sham-OP for the CLP procedure
(Figure 1, A and B). The relative increases in mRNA for IL-
17F were much lower compared with IL-17A, which might
be explained by higher baseline mRNA expression in spleens
from mice after sham-OP (Figure 1, A and B). The plasma
levels of IL-17A, IL-17F, and IL-17AF were compared at
various time points after endotoxemia in C57BL/6 mice
(Figure 1C). All three IL-17 isoforms reached a plateau
between 6 and 12 hours. The plasma concentrations for IL-
17A were found to be much lower than those for IL-17F
(ﬁvefold) and IL-17AF (10-fold). The data in Figure 1CFigure 3 In vitro suppression of IL-17 family members by catecholamines and
mice were either untreated (Ctrl) or incubated with 1 mg/mL LPS for 10 hours and
ELISA in supernatant ﬂuids. B: Suppression of IL-17A secretion in 1 mg/mL LP
adrenaline or noradrenaline (x axis: log scale). IL-17A concentrations released
independent samples at 10 hours. C: Suppression of IL-17A by different doses o
Suppression of IL-17F by adrenaline or noradrenaline from the same experiments a
from the same experiments as shown in C. F: Suppression of IL-17AF release by
Suppression of IL-17AF by hydrocortisone or dexamethasone from the same exper
isoforms by adrenaline or dexamethasone compared with PECs with LPS alone. All e
0.01, and ***P < 0.001.
The American Journal of Pathology - ajp.amjpathol.orgsuggest that the IL-17AF heterodimer in plasma after endo-
toxemia is the predominant species.
To investigate the roles of catecholamines and glucocor-
ticoids in the production of IL-17 family members during
sepsis, we used mice in which the adrenal glands had been
surgically removed several weeks before sepsis induction.
We conﬁrmed that after adrenalectomy, mice had much
higher mortality rates in the models of endotoxemia and CLP
(Figure 2, A and G). After endotoxemia, all adrenalecto-
mized mice died in fewer than 2 days, whereas all mice after
sham surgery for the adrenalectomy procedure survived
(Figure 2A). In the CLP model, the survival of adrenalec-
tomized mice was 0% (day 3) compared with 80% survival
(at 160 h) for mice with intact adrenal glands (Figure 2G).
The increased susceptibility of adrenalectomized mice after
endotoxemia correlated with much higher plasma concen-
trations of IL-17A, IL-17F, and IL-17AF after 8 hours
(Figure 2, BeD). Likewise, adrenalectomy resulted in
much higher concentrations of IL-23 after endotoxemia
(Figure 2E). Blockade of IL-23 using neutralizing antibody
reduced the amounts of IL-17A in endotoxemia by approx-
imately 50% (Figure 2F). We previously reported that in
endotoxemia the appearance of IL-23 in plasma precedes
production of IL-17A.7 Hence, the hyperproduction of IL-23glucocorticoids in LPS-stimulated PECs. A: Cultures of PECs from C57BL/6
concentrations of secreted IL-17A, IL-17F, and IL-17AF were measured by
S-activated PECs by co-incubation with different concentrations of either
after LPS alone were used as 100%. Each data point represents 3 to 4
f hydrocortisone or dexamethasone in LPS-activated PECs at 10 hours. D:
s shown in B. E: Suppression of IL-17F by hydrocortisone or dexamethasone
adrenaline or noradrenaline from the same experiments as shown in B. G:
iments as shown in C. H: Relative inhibition of mRNA for IL-17A and IL-17F
xperiments were performed with PECs from C57BL/6 mice. *P < 0.05, **P <
1127
Figure 4 Catecholamines and glucocorticoids reduce activation of JNK
to mediate inhibition of IL-17 family members. A: Bead-based assay of
phosphorylated JNK in lysates of PECs (C57BL/6) activated for 60 minutes
with 1 mg/mL LPS alone or after pretreatment (60 minutes) with 1 mmol/L
adrenaline (A), 1 mmol/L noradrenaline (NA), 1 mmol/L hydrocortisone
(HC), or 1 mmol/L dexamethasone (Dexa). B: Dependency of secretion of
IL-17A, IL-17F, and IL-17AF on JNK activation. PECs (C57BL/6) were pre-
treated with 10 mmol/L JNK inhibitors for 60 minutes (SP600125 or
AEG3482) followed by 1 mg/mL LPS for 10 hours before detection of IL-17
isoforms. *P < 0.05, **P < 0.01, and ***P < 0.001.
Bosmann et alin adrenalectomized mice may contribute to the higher
concentrations of IL-17A seen in such mice.
In CLP mice, plasma levels of IL-17A, IL-17F, and IL-
17AF were all more than ﬁvefold higher when compared
with mice with functional adrenal glands (Figure 2, HeJ). In
control mice that underwent sham procedures for both
adrenalectomy and CLP, the IL-17 family members were
almost undetectable in plasma (Figure 2, HeJ). These data
suggest that endogenous adrenal hormones suppressed the
appearance of IL-17 family members during the acute
inﬂammatory response in the two septic models used.
Catecholamines and Glucocorticoids Suppress the
in Vitro Production of IL-17 Family Members
We sought to investigate which factors known to be secreted
by the adrenal glands might regulate the production of IL-17
family members. We used in vitro cultures of mouse PECs,
which are predominantly macrophages.7 We recently
described PECs as a source for either IL-17A or IL-17F.7,14
Quantitative comparison of concentrations for IL-17A, IL-
17F, and IL-17AF released from PECs stimulated with LPS
revealed the IL-17AF isoform to be most abundant 10 hours
after the addition of LPS (Figure 3A). This was in accor-
dance with the ﬁndings obtained with the CLP and endo-
toxemia models (Figures 1 and 2). Cultures of PECs were
incubated with 1 mg/mL LPS alone or in combination with
different doses of adrenaline, noradrenaline, hydrocortisone,
or dexamethasone (dose range, 109 to 106 mol/L). The
presence of 106 mol/L of adrenaline or noradrenaline in
cultures of LPS-activated PECs reduced the release of IL-
17A to 20% (Figure 3B). As expected, dexamethasone
showed higher potency than hydrocortisone in suppressing
IL-17A (Figure 3C). Adrenaline and noradrenaline only
modestly suppressed IL-17F (Figure 3D), whereas IL-17F
was strongly reduced by the presence of glucocorticoids
(hydrocortisone, dexamethasone) (Figure 3E). With higher
concentrations of catecholamines, IL-17AF production
decreased by 40% when values after LPS activation alone
were used as 100% (Figure 3F). Glucocorticoids nearly
completely inhibited IL-17AF at 106 mol/L (Figure 3G).
At lower concentrations (108 mol/L, 107 mol/L), the effects
seen with noradrenaline were less when compared with those
in the presence of adrenaline (Figure 3, B, D, and F). When
mRNA levels for the IL-17A and IL-17F subunits were
studied, these mRNAs also were reduced by catecholamines
and glucocorticoids (106 mol/L) (Figure 3H). This suggests
that catecholamines and glucocorticoids regulate the release of
IL-17 family members at the transcriptional level (or affect
mRNA stability).
Role of the JNK Pathway for Production of IL-17 Family
Members
To characterize what signaling mechanisms may be targeted
by adrenal gland hormones to suppress IL-17 family1128members, we turned our attention to the JNK pathway. We
used bead-based assays speciﬁc for relative quantitative
detection of JNK when phosphorylated at Thr183/Tyr185.
Incubation of PECs (from C57BL/6 mice) with LPS for
60 minutes increased the levels of phospho-JNK 2.5-fold
above untreated controls (Figure 4A). Pretreatment of
PECs for 60 minutes with 1 mmol/L of either adrenaline or
noradrenaline as well as hydrocortisone, or dexamethasone
substantially diminished JNK phosphorylation (Figure 4A).
To assess if activation of JNK was required for the release
of IL-17 family members after LPS, we used speciﬁc
small-molecule inhibitors to block JNK1/JNK2 isoforms
(Figure 4B). SP600125 and AEG3482 (each at 10 mmol/L)
signiﬁcantly antagonized the production of IL-17A,
IL-17F, and IL-17AF in cultures of LPS-activated PECs
(Figure 4B). Collectively, these data suggest that cate-
cholamines and glucocorticoids may both target the JNK
pathway to regulate the acute release of IL-17 family
members.ajp.amjpathol.org - The American Journal of Pathology
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Our ﬁndings indicate that catecholamines and glucocorti-
coids suppress gene expression and release of IL-17A, IL-
17F, and IL-17AF during sepsis (CLP and endotoxemia)
and in cultures of LPS-activated PECs (macrophages).
Endogenous IL-23 appears to enhance IL-17A plasma
concentrations after adrenalectomy/endotoxemia. It has long
been known that adrenalectomized animals are much more
sensitive to the lethal effects of endotoxin, IL-1, and tumor
necrosis factor (TNF).22e24 We have shown in earlier
reports that neutralization of IL-17A was protective in
deﬁned settings of lethal endotoxemia and severe poly-
microbial sepsis by reduction of TNFa, IL-1b, IL-6, and
HMGB1 release and up-regulation of IL-10 and trans-
forming growth factor-b.7,8 In addition, we found that IL-
17A by itself has minimal effects on TNFa, IL-1b, and
IL-6 production from peritoneal macrophages; whereas in
the co-presence of LPS there was signiﬁcant augmentation
of mediator production.8 These ﬁndings may suggest that the
hyperproduction of IL-17 family members in adrenalecto-
mized mice during sepsis may have contributed to the
impaired survival of these mice. On the other hand, when
nonsevere polymicrobial sepsis was studied, IL-17R-deﬁcient
mice showed reduced recruitment of polymorphonuclear
leukocytes and defective bacterial clearance together with
increased mortality.25
Secretion of catecholamines and glucocorticoids from the
adrenal glands is an integral part of the stress response
during critical illness.26 In addition to their metabolic
effects, glucocorticoids are potent regulators of transcrip-
tional activity (transactivation or transrepression) of genes
with immunologic functions. Multiple proinﬂammatory
cytokines are antagonized by glucocorticoids including IL-
1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-11, IL-13, IL-16, gran-
ulocyte-macrophage colony-stimulating factor, TNFa, and
the chemokines IL-8, regulated on activation normal T-cell
expressed and secreted, eotaxin, macrophage inﬂammatory
protein 1a, and monocyte chemoattractant protein-1.27
Production of IL-17 is inhibited by methylprednisolone in
cultures of peripheral blood mononuclear cells from healthy
humans.28 In addition, the biological effects of IL-17 are
suppressed in the presence of glucocorticoids.29,30 In
patients with rheumatoid arthritis, treatment with glucocor-
ticoids may be associated with lower numbers of IL-
17þCD4þ cells.31 In a model of murine allergic asthma,
Th17 cells displayed only a limited responsiveness to
dexamethasone.32 During the past decades, the treatment
regimens for the use of glucocorticoids during sepsis have
undergone dramatic changes. According to current guide-
lines, only low-dose glucocorticoids are advisable (if at all)
for use in septic shock.9
On the other hand, the effectiveness of catecholamines for
blood pressure instability treatment during sepsis is indis-
putable.9 Adrenaline and noradrenaline are the principal
sympathetic neurotransmitters and participate in the reﬂexThe American Journal of Pathology - ajp.amjpathol.orgcontrol of immunity.33 Catecholamines regulate lymphocyte
functions including an inhibition of proliferation and cyto-
toxicity of CD4þ and CD8þ cells.34,35 Adrenaline or b2
adrenergic agonists inhibit the production of TNFa from
human or mouse immune cells.36,37 During experimental
human endotoxemia, the continuous infusion of adrenaline
reduced plasma TNFa concentrations, whereas IL-10 levels
were enhanced.38 Noradrenaline inhibits the production of
both TNFa and IL-6 in cultures of human whole blood.39
Notably, catecholamines are produced not only in the
adrenal medulla but to some extent by innate immune cells
facilitating autocrine and paracrine feedback loops.6,40e42 In
some experimental settings, catecholamines at very low
concentrations may promote the inﬂammatory response.41,42
Similar to the ﬁndings in this report, the phosphorylation
of JNK in PECs after LPS activation was antagonized by
b2 adrenergic-receptor agonists.36 In conclusion, adrenal
hormones appear to interfere with the release of IL-17
family members. Such observations may be of importance
for understanding the immune modulatory effects of cate-
cholamines and glucocorticoids during sepsis and other
states of acute inﬂammation.Acknowledgments
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